Download presentation
Presentation is loading. Please wait.
Published bySudirman Halim Modified over 6 years ago
1
Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy
Ana I. Tabar, MD, PhD, Esozia Arroabarren, MD, Susana Echechipía, MD, PhD, Blanca E. García, MD, PhD, Santiago Martin, MS, María J. Alvarez-Puebla, MD, PhD Journal of Allergy and Clinical Immunology Volume 127, Issue 1, Pages e3 (January 2011) DOI: /j.jaci Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig 1 Study design. Arrows, Randomization. Red triangle, STOP immunotherapy. T0 to T1: results published in Tabar AI, Echechipía S, García BE, Olaguibel JM, Lizaso MT, Gómez B, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005;116: Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 2 Patients’ flowchart throughout the study.
Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
4
Fig 3 A, Rhinitis severity (global score). B, Asthma severity (global score). C, VAS score. Mean values (black line) (SEs).∗P < CO, Control group. Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
5
Fig 4 RQLQ and AQLQ scores. A, IT5. B, IT3. C, Control group. Mean values (black line) (SEs). ∗P < .01. Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.